Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gowen

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
The Journal of Infectious Diseases|May 16, 2018
Effective Treatment of Experimental Lymphocytic Choriomeningitis Virus Infection: Consideration of Favipiravir for Use With Infected Organ Transplant RecipientsBrady T Hickerson, Jonna B Westover, Kie-Hoon Jung, et al.
Plos One|December 20, 2007
Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis diseaseXin Ma, Yuhua Liu, Brian B Gowen, et al.
Antiviral Research|October 31, 2009
Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease modelsBrian B Gowen, Min-Hui Wong, Kie-Hoon Jung, et al.
Journal of Molecular Biology|October 8, 1998
The first step: activation of the Semliki Forest virus spike protein precursor causes a localized conformational change in the trimeric spikeI Ferlenghi, B Gowen, F de Haas, et al.
Antiviral Research|March 26, 2013
Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challengeBrian B Gowen, Kevin W Bailey, Dionna Scharton, et al.
Plos Neglected Tropical Diseases|October 25, 2011
Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic FeverMichelle Mendenhall, Andrew Russell, Donald F Smee, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2012
Extended protection against phlebovirus infection conferred by recombinant adenovirus expressing consensus interferon (DEF201)Brian B Gowen, Jane Ennis, Eric J Sefing, et al.
Viruses|March 26, 2014
Single-dose intranasal treatment with DEF201 (adenovirus vectored consensus interferon) prevents lethal disease due to Rift Valley fever virus challengeBrian B Gowen, Jane Ennis, Kevin W Bailey, et al.
Vaccines|January 8, 2025
Safety, Immunogenicity, and Efficacy of a Recombinant Vesicular Stomatitis Virus Vectored Vaccine Against Severe Fever with Thrombocytopenia Syndrome Virus and Heartland BandavirusPhilip Hicks, Tomaz B Manzoni, Jonna B Westover, et al.
Antiviral Chemistry & Chemotherapy|January 23, 2013
Activity of a phenolic dibenzylsulfide against New World arenavirus infectionsBrian B Gowen, Kie-Hoon Jung, Eric J Sefing, et al.
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
The Journal of Infectious Diseases|May 16, 2018
Effective Treatment of Experimental Lymphocytic Choriomeningitis Virus Infection: Consideration of Favipiravir for Use With Infected Organ Transplant RecipientsBrady T Hickerson, Jonna B Westover, Kie-Hoon Jung, et al.
Plos One|December 20, 2007
Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis diseaseXin Ma, Yuhua Liu, Brian B Gowen, et al.
Antiviral Research|October 31, 2009
Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease modelsBrian B Gowen, Min-Hui Wong, Kie-Hoon Jung, et al.
Journal of Molecular Biology|October 8, 1998
The first step: activation of the Semliki Forest virus spike protein precursor causes a localized conformational change in the trimeric spikeI Ferlenghi, B Gowen, F de Haas, et al.
Antiviral Research|March 26, 2013
Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challengeBrian B Gowen, Kevin W Bailey, Dionna Scharton, et al.
Plos Neglected Tropical Diseases|October 25, 2011
Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic FeverMichelle Mendenhall, Andrew Russell, Donald F Smee, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2012
Extended protection against phlebovirus infection conferred by recombinant adenovirus expressing consensus interferon (DEF201)Brian B Gowen, Jane Ennis, Eric J Sefing, et al.
Viruses|March 26, 2014
Single-dose intranasal treatment with DEF201 (adenovirus vectored consensus interferon) prevents lethal disease due to Rift Valley fever virus challengeBrian B Gowen, Jane Ennis, Kevin W Bailey, et al.
Vaccines|January 8, 2025
Safety, Immunogenicity, and Efficacy of a Recombinant Vesicular Stomatitis Virus Vectored Vaccine Against Severe Fever with Thrombocytopenia Syndrome Virus and Heartland BandavirusPhilip Hicks, Tomaz B Manzoni, Jonna B Westover, et al.
Antiviral Chemistry & Chemotherapy|January 23, 2013
Activity of a phenolic dibenzylsulfide against New World arenavirus infectionsBrian B Gowen, Kie-Hoon Jung, Eric J Sefing, et al.
Pageof 12